C

CirChem AB
STO:CIRCHE

Watchlist Manager
CirChem AB
STO:CIRCHE
Watchlist
Price: 2.65 SEK -0.38% Market Closed
Market Cap: 82.6m SEK
Have any thoughts about
CirChem AB?
Write Note

Intrinsic Value

CIRCHE's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one CIRCHE stock under the Base Case scenario is 0.7 SEK. Compared to the current market price of 2.65 SEK, CirChem AB is Overvalued by 74%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CIRCHE Intrinsic Value
0.7 SEK
Overvaluation 74%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation Backtest
CirChem AB

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for CIRCHE cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about CIRCHE?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Chemicals Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about CirChem AB

Provide an overview of the primary business activities
of CirChem AB.

What unique competitive advantages
does CirChem AB hold over its rivals?

What risks and challenges
does CirChem AB face in the near future?

Has there been any significant insider trading activity
in CirChem AB recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for CirChem AB.

Provide P/S
for CirChem AB.

Provide P/E
for CirChem AB.

Provide P/OCF
for CirChem AB.

Provide P/FCFE
for CirChem AB.

Provide P/B
for CirChem AB.

Provide EV/S
for CirChem AB.

Provide EV/GP
for CirChem AB.

Provide EV/EBITDA
for CirChem AB.

Provide EV/EBIT
for CirChem AB.

Provide EV/OCF
for CirChem AB.

Provide EV/FCFF
for CirChem AB.

Provide EV/IC
for CirChem AB.

Compare the intrinsic valuations
of CirChem AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of CirChem AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of CirChem AB compared to its peers.

Compare the P/E ratios
of CirChem AB against its peers.

Discuss the investment returns and shareholder value creation
comparing CirChem AB with its peers.

Analyze the financial leverage
of CirChem AB compared to its main competitors.

Show all profitability ratios
for CirChem AB.

Provide ROE
for CirChem AB.

Provide ROA
for CirChem AB.

Provide ROIC
for CirChem AB.

Provide ROCE
for CirChem AB.

Provide Gross Margin
for CirChem AB.

Provide Operating Margin
for CirChem AB.

Provide Net Margin
for CirChem AB.

Provide FCF Margin
for CirChem AB.

Show all solvency ratios
for CirChem AB.

Provide D/E Ratio
for CirChem AB.

Provide D/A Ratio
for CirChem AB.

Provide Interest Coverage Ratio
for CirChem AB.

Provide Altman Z-Score Ratio
for CirChem AB.

Provide Quick Ratio
for CirChem AB.

Provide Current Ratio
for CirChem AB.

Provide Cash Ratio
for CirChem AB.

What is the historical Revenue growth
over the last 5 years for CirChem AB?

What is the historical Net Income growth
over the last 5 years for CirChem AB?

What is the current Free Cash Flow
of CirChem AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for CirChem AB.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
CirChem AB

Current Assets 16.5m
Cash & Short-Term Investments 14m
Receivables 1.8m
Other Current Assets 635k
Non-Current Assets 43.1m
PP&E 43.1m
Current Liabilities 18.5m
Accounts Payable 2.6m
Accrued Liabilities 1.9m
Other Current Liabilities 14m
Non-Current Liabilities 7.1m
Long-Term Debt 7.1m
Efficiency

Earnings Waterfall
CirChem AB

Revenue
8.2m SEK
Cost of Revenue
-7.2m SEK
Gross Profit
1m SEK
Operating Expenses
-11.7m SEK
Operating Income
-10.7m SEK
Other Expenses
-1m SEK
Net Income
-11.7m SEK

Free Cash Flow Analysis
CirChem AB

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

CIRCHE Profitability Score
Profitability Due Diligence

CirChem AB's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 1-Year Revenue Growth
Negative Operating Income
Negative Net Income
25/100
Profitability
Score

CirChem AB's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

CIRCHE Solvency Score
Solvency Due Diligence

CirChem AB's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Negative Net Debt
Short-Term Solvency
55/100
Solvency
Score

CirChem AB's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CIRCHE Price Targets Summary
CirChem AB

There are no price targets for CIRCHE.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CIRCHE?

Click here to dive deeper.

Dividends

CirChem AB
does not pay dividends
Shareholder Yield

Current shareholder yield for CIRCHE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

CIRCHE Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

CirChem AB

Country

Sweden

Industry

Chemicals

Market Cap

82.6m SEK

Dividend Yield

0%

Description

CirChem AB engages in the manufacture and trade of chemical products that recycle solvents used in the manufacturing industry. The firm's mission is to offer the industry a profitable way to recycle solvents locally and at the same time reduce its climate footprint. CirChem offers circular recycling of several different types of solvents on an industrial scale through distillation technology. The firm cleans and refines used solvent, so that it can be used again. Solvent reuse contributes to both increased resource efficiency and reduced CO2 emissions. Using circular chemistry, CirChem contributes to both industry and the climate. The firm's offering consists of climate smart products such as hand sanitizers and washer fluids as well.

Contact

VASTRA GOTALANDS
Malderistvagen 3, Vargon
+46708611780
circhem.com

IPO

2020-12-09

Employees

-

Officers

CEO & Director
Mr. Petra Sas
Chief Financial Officer
Mr. Kristofer Svensson
Chief Operating Officer
Andreas Wadstedt

See Also

Discover More
What is the Intrinsic Value of one CIRCHE stock?

The intrinsic value of one CIRCHE stock under the Base Case scenario is 0.7 SEK.

Is CIRCHE stock undervalued or overvalued?

Compared to the current market price of 2.65 SEK, CirChem AB is Overvalued by 74%.

Back to Top